A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients-Reference-Cited by-同舟云学术

A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

Published:2021-11-20 Issue:2 Volume:57 Page:295-298
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tan Carlyn Rose^ORCID,Estrada-Merly Noel,Landau Heather^ORCID,Lekakis Lazaros,Banerjee Rahul,Mian Hira^ORCID,Usmani Saad Z.,Hanbali Amr,Lazarus Hillard M.^ORCID,Kyle Robert A.,Dholaria Bhagirathbhai^ORCID,Bal Susan,Strouse Christopher^ORCID,Murthy Hemant S.,Wirk Baldeep^ORCID,Nishihori Taiga^ORCID,Kumar Shaji^ORCID,Shah Nina,Qazilbash Muzaffar^ORCID,D’Souza Anita^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01527-z.pdf

Reference11 articles.

1. D’Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, et al. Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for International Blood and Marrow Transplant Research Study. J Clin Oncol.2015;33:3741–9. https://doi.org/10.1200/JCO.2015.62.4015

2. Cornell RF, Fraser R, Costa L, Goodman S, Estrada-Merly N, Lee C, et al. Bortezomib-based induction Is associated with superior outcomes in light chain amyloidosis patients treated with autologous hematopoietic cell transplantation regardless of plasma cell burden. Transpl Cell Ther. 2021;27:264 e261–264 e267. https://doi.org/10.1016/j.jtct.2020.11.018.

3. Cook G, Ashcroft AJ, Cairns DA, Williams CD, Brown JM, Cavenagh JD, et al. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. Lancet Haematol. 2016;3:e340–351. https://doi.org/10.1016/S2352-3026(16)30049-7.

4. Dhakal B, D’Souza A, Kleman A, Chhabra S, Mohan M, Hari P. Salvage second transplantation in relapsed multiple myeloma. Leukemia. 2020;35:1214–17. https://doi.org/10.1038/s41375-020-1005-8.

5. Muchtar E, Dispenzieri A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, et al. Second stem cell transplantation for relapsed refractory light chain (AL) amyloidosis. Transpl Cell Ther. 2021;27:589 e581–589 e586. https://doi.org/10.1016/j.jtct.2021.03.031.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies;The Lancet Haematology;2023-11

2. Individualized Approach to Management of Light Chain Amyloidosis;Journal of the National Comprehensive Cancer Network;2023-01